Patrick Laurent Selected Research

Opioid Analgesics (Opioids)

1/2006

RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick Laurent Research Topics

Disease

3	Inflammation (Inflammations) 01/2019 - 12/2017
2	Hyperalgesia 01/2006 - 12/2005
1	Bacterial Infections (Bacterial Infection) 08/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Infections 07/2014
1	Chronic Pain 01/2006
1	Pain (Aches) 01/2006

Drug/Important Bio-Agent (IBA)

1	LipopolysaccharidesIBA 08/2019
1	SilicatesIBA 11/2018
1	CytokinesIBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	Complement System Proteins (Complement)IBA 07/2014
1	neuropeptide FF receptorIBA 01/2006
1	Opioid Analgesics (Opioids)IBA 01/2006
1	Heroin (Diamorphine)IBA 01/2006
1	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 01/2006
1	Morphine (MS Contin)FDA LinkGeneric 12/2005

Therapy/Procedure

3	Dental Pulp Capping 01/2019 - 12/2017